101 related articles for article (PubMed ID: 38761662)
1. Multi-targeted nanoarrays for early broad-spectrum detection of lung cancer based on blood biopsy of tumor exosomes.
Lian S; Wang Q; Liu Y; Lu Y; Huang L; Deng H; Xie X
Talanta; 2024 May; 276():126270. PubMed ID: 38761662
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical Au nanoarrays functionalized 2D Ti
You Q; Zhuang L; Chang Z; Ge M; Mei Q; Yang L; Dong WF
Biosens Bioelectron; 2022 Nov; 216():114647. PubMed ID: 36029661
[TBL] [Abstract][Full Text] [Related]
3. Artificially Intelligent Nanoarray Detects Various Cancers by Liquid Biopsy of Volatile Markers.
Einoch Amor R; Zinger A; Broza YY; Schroeder A; Haick H
Adv Healthc Mater; 2022 Sep; 11(17):e2200356. PubMed ID: 35765713
[TBL] [Abstract][Full Text] [Related]
4. Affibody Functionalized Beads for the Highly Sensitive Detection of Cancer Cell-Derived Exosomes.
Sayyadi N; Zhand S; Razavi Bazaz S; Warkiani ME
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769444
[TBL] [Abstract][Full Text] [Related]
5. Exosomes as a liquid biopsy for lung cancer.
Cui S; Cheng Z; Qin W; Jiang L
Lung Cancer; 2018 Feb; 116():46-54. PubMed ID: 29413050
[TBL] [Abstract][Full Text] [Related]
6. Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes.
Shin H; Oh S; Hong S; Kang M; Kang D; Ji YG; Choi BH; Kang KW; Jeong H; Park Y; Hong S; Kim HK; Choi Y
ACS Nano; 2020 May; 14(5):5435-5444. PubMed ID: 32286793
[TBL] [Abstract][Full Text] [Related]
7. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery.
Buscail E; Alix-Panabières C; Quincy P; Cauvin T; Chauvet A; Degrandi O; Caumont C; Verdon S; Lamrissi I; Moranvillier I; Buscail C; Marty M; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S; Chiche L
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717747
[TBL] [Abstract][Full Text] [Related]
8. Rapid immunomagnetic co-capture assay for quantification of lung cancer associated exosomes.
Singh S; Pathak A; Kumar S; Malik PS; Elangovan R
J Immunol Methods; 2022 Sep; 508():113324. PubMed ID: 35878721
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
Srivastava A; Rathore S; Munshi A; Ramesh R
AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
[TBL] [Abstract][Full Text] [Related]
10. Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice.
Masaoutis C; Mihailidou C; Tsourouflis G; Theocharis S
Biochimie; 2018 Aug; 151():27-36. PubMed ID: 29857182
[TBL] [Abstract][Full Text] [Related]
11. Exosomes as Theranostics for Lung Cancer.
Srivastava A; Amreddy N; Razaq M; Towner R; Zhao YD; Ahmed RA; Munshi A; Ramesh R
Adv Cancer Res; 2018; 139():1-33. PubMed ID: 29941101
[TBL] [Abstract][Full Text] [Related]
12. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
Xiao W; Ma W; Wei S; Li Q; Liu R; Carney RP; Yang K; Lee J; Nyugen A; Yoneda KY; Lam KS; Li T
J Hematol Oncol; 2019 Jun; 12(1):56. PubMed ID: 31182116
[TBL] [Abstract][Full Text] [Related]
13. Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer.
Yu Z; Yang Y; Fang W; Hu P; Liu Y; Shi J
ACS Nano; 2023 Jun; 17(12):11384-11395. PubMed ID: 37288703
[TBL] [Abstract][Full Text] [Related]
14. Molecular biomarkers and liquid biopsies in lung cancer.
Sankar K; Zeinali M; Nagrath S; Ramnath N
Semin Oncol; 2022 Jul; ():. PubMed ID: 35820969
[TBL] [Abstract][Full Text] [Related]
15. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
Li G; Tang W; Yang F
Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment.
Rahimian S; Najafi H; Afzali B; Doroudian M
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255228
[TBL] [Abstract][Full Text] [Related]
18. GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer.
Jeong H; Choi BH; Park J; Jung JH; Shin H; Kang KW; Quan YH; Yu J; Park JH; Park Y; Choi Y; Kim HK; Hong S
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771645
[TBL] [Abstract][Full Text] [Related]
19. Exosome beads array for multiplexed phenotyping in cancer.
Jara-Acevedo R; Campos-Silva C; Valés-Gómez M; Yáñez-Mó M; Suárez H; Fuentes M
J Proteomics; 2019 Apr; 198():87-97. PubMed ID: 30594577
[TBL] [Abstract][Full Text] [Related]
20. Exosomes in Lung Cancer: Actors and Heralds of Tumor Development.
Sandúa A; Alegre E; González Á
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
